These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 32144)

  • 1. Dissociation between clinical and exercise responsiveness to beta-blockade in angina.
    Tremblay G; Biron P; Proulx A
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):508-12. PubMed ID: 32144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acebutolol in angina pectoris: objective assessment using graded treadmill testing.
    Kimchi A; Gotsman MS; Lewis BS
    Isr J Med Sci; 1978 Sep; 14(9):941-7. PubMed ID: 363642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D; Kamchi A; Lewis BS; Gotsman MS
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease.
    Steele P; Gold F
    Chest; 1982 Jul; 82(1):40-3. PubMed ID: 7044708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
    Glasser SP; Gana TJ; Pascual LG; Albert KS
    Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nipradilol, a new beta-blocking agent with vasodilating properties, on exercise tolerance in patients with stable effort angina: a double-blind study.
    Araki H; Hayata N; Nakamura M
    Clin Ther; 1987; 9(6):656-62. PubMed ID: 2894246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acebultolol: basis for the prediction of effect on exercise tolerance.
    Biron P; Tremblay G
    Clin Pharmacol Ther; 1976 Mar; 19(3):333-8. PubMed ID: 4256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina.
    De Ponti C; De Biase AM; Pirelli S; Cataldo G; Salvadé P; Lanocita M; Carù B
    Cardiology; 1981; 68 Suppl 2():195-9. PubMed ID: 7032697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of nicardipine, a new calcium antagonist, versus nifedipine in effort stable angina.
    Di Pasquale G; Lusa AM; Manini GL; Dominici P; Coluccini M; Bassein L; Pinelli G
    G Ital Cardiol; 1984 Aug; 14(8):618-20. PubMed ID: 6500225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
    Ruzyllo W; Szwed H; Sadowski Z; Elikowski W; Grzelak-Szafranska H; Orszulak W; Szymczak K; Winter M
    Curr Med Res Opin; 2004 Sep; 20(9):1447-54. PubMed ID: 15383193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectoris.
    Hansen JF; Grytter C; Thomsen S; Sigurd B
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():31-41. PubMed ID: 6126287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-blockade on right ventricular performance in patients with and without right ventricular dysfunction due to coronary artery disease.
    Singh A; Alpert MA; Sanfelippo JF; Mukerji V; Villarreal D; Holmes RA; Sunderrajan EV; Morgan RJ
    Arch Intern Med; 1986 Nov; 146(11):2135-9. PubMed ID: 2877643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.